Are liver function tests recommended with tigecycline use?

Are liver function tests recommended when using tigecycline?

Yes. Liver function monitoring is recommended during tigecycline therapy, because the drug can cause liver-related lab abnormalities. Tigecycline’s prescribing information includes guidance to monitor liver tests during treatment. [1]

What liver tests are typically monitored?

The usual approach is to check liver function tests such as serum transaminases (AST/ALT) and bilirubin during therapy, consistent with how hepatotoxicity and biliary/liver injury are typically tracked in clinical practice and in labeling recommendations. [1]

Why do clinicians monitor liver tests with tigecycline?

Tigecycline can lead to increases in liver enzymes and bilirubin. Monitoring helps detect clinically significant liver test worsening early, so dose decisions and further evaluation can be made if abnormalities occur. [1]

What about patients who already have liver disease or elevated baseline labs?

Liver monitoring is especially important in patients with underlying hepatic impairment or abnormal baseline liver tests, since they may be at higher risk for further lab worsening during treatment. Labeling supports ongoing liver test monitoring during use. [1]

How should liver test abnormalities be handled?

The appropriate response depends on the severity and the overall clinical picture. The core practical point from the labeling is to monitor liver tests during treatment; if significant abnormalities develop, clinicians typically reassess therapy and evaluate other causes of liver injury while continuing to follow labeled guidance. [1]

Sources

1. FDA label for Tygacil (tigecycline)